Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL
Clinical trial NCT05464836 · TERMINATED
Trial details
- NCT number
- NCT05464836
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2024-08-12
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.